Clinical and laboratory characteristics of a group of patients with autoimmune lymphoproliferative syndrome

Cover Page

Cite item

Full Text

Abstract

Autoimmune lymphoproliferative syndrome (ALPS) is characterized by abnormal lymphocyte homeostasis due to the defect of Fas-mediated apoptosis. Symptoms include lymphoproliferation, autoimmune complications, increased double-negative α/β+-Т cells (DNT) and vitamin B12 concentration and hypergammaglobulinemia. The study group included 22 patients with ALPS, and eight symptoms-free relatives who carried respective mutations. Thirteen patients had various Fas gene mutations, two – the same mutation of Casp10, in seven patients genetic defect has not been found. Symptoms included combination of cytopenia and lymphoproliferation (n = 17), increased biomarkers: high DNT (Ме = 8,9%) were found in 19 patients, high B12 levels – in 13 patients. B12 level correlated with disease severity, predominantly with lymphoproliferation, which can be used as a marker of disease severity. Due to the heterogeneous nature of ALPS symptoms molecular genetic test play an important role in diagnostic testing of the patients and their relatives.

About the authors

O. A. Shvetz

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Author for correspondence.
Email: shv18081979@gmail.com

MD, pediatrician allergologist/immunologist, outpatient department

Russia 117997, Moscow, Samory Mashela st., 1

+7 (495) 287-6570, доб. 1172

Россия

E. V. Deripapa

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

V. V. Zakharova

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

D. S. Abramov

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

E. A. Deordieva

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

E. A. Victorova

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

I. N. Abramova

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

Yu. A. Rodina

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

O. A. Shragina

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

D. D. Baildildina

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

I. I. Kalinina

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

Y. N. Petrova

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

ORCID iD: 0000-0002-1258-8281
Россия

E. V. Raikina

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

ORCID iD: 0000-0002-7634-2053
Россия

D. M. Konovalov

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

Россия

A. V. Pshonkin

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

ORCID iD: 0000-0002-2057-2036
Россия

M. A. Machan

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

ORCID iD: 0000-0002-0016-6698
Россия

A. Yu. Shcherbina

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

ORCID iD: 0000-0002-3113-4939
Россия

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 «D. Rogachev NMRCPHOI»

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.